DNA X, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/095fba81-b012-4b81-8096-d51a72ade6d9/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $50.9M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-001720 |
| FY 2023 | $93.6M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-011530 |
| FY 2022 | $69.8M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-008199 |
| FY 2021 | $54.6M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-011226 |
| FY 2020 | $64.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014012 |
| FY 2019 | $116.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013676 |
| FY 2018 | $135.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-20-013676 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).